EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease

Caren Doueiry iD, Christiana S Kappler iD, Carla Martinez-Morant iD, Stephen A Duncan iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Caren Doueiry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Hepatocytes, Induced Pluripotent Stem Cells, Membrane Proteins, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of nonalcoholic fatty liver disease (NAFLD), or metabolic dysfunction-associated fatty liver disease (MAFLD), is increasing in adults and children. Unfortunately, effective pharmacological treatments remain unavailable. Single nucleotide polymorphisms (SNPs) in the patatin-like phospholipase domain-containing protein (PNPLA3 I148M) have the most significant genetic association with the disease at all stages of its progression. A roadblock to identifying potential treatments for PNPLA3-induced NAFLD is the lack of a human cell platform that recapitulates the PNPLA3 I148M-mediated onset of lipid accumulation. Hepatocyte-like cells were generated from PNPLA3−/− and PNPLA3I148M/M-induced pluripotent stem cells (iPSCs). Lipid levels were measured by staining with BODIPY 493/503 and were found to increase in PNPLA3 variant iPSC-derived hepatocytes. A small-molecule screen identified multiple compounds that target Src/PI3K/Akt signaling and could eradicate lipid accumulation in these cells. We found that drugs currently in clinical trials for cancer treatment that target the same pathways also reduced lipid accumulation in PNPLA3 variant cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesInduced Pluripotent Stem CellsMembrane ProteinsNon-alcoholic Fatty Liver DiseaseLipaseHumansSignal TransductionLipid MetabolismPolymorphism, Single NucleotideAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

MAFLDNAFLDdrug discoverysmall moleculessteatosisstem cells

Substanzen

PNPLA3 protein, humanMembrane ProteinsLipaseAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Medical Scientist Training Program, Medical University of South Carolina, Charleston, SC 29425, USA.

ORCID-Profile: Caren Doueiry, Christiana S Kappler, Carla Martinez-Morant, Stephen A Duncan

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institute of Health

Zitieren

APA

Doueiry, C., Kappler, C. S., Martinez-Morant, C., & Duncan, S. A. (2024). A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137277

Vancouver

Doueiry C, Kappler CS, Martinez-Morant C, Duncan SA. A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137277

BibTeX
@article{Doueiry2024,
  author = {Doueiry, Caren and Kappler, Christiana S and Martinez-Morant, Carla and Duncan, Stephen A},
  title = {A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137277}
}
Kostenlos starten →